Herpes Simplex Virus-2 (HSV-2) is a significant human pathogen primarily associated with genital infections. It is a member of the Herpesviridae family, which also includes HSV-1, known for causing orofacial lesions. HSV-2 infections are widespread and can lead to severe health complications, including neonatal herpes, encephalitis, and an increased risk of HIV transmission.
Glycoprotein G (gG) is one of the envelope glycoproteins of HSV-2. It plays a crucial role in the virus’s ability to infect host cells and evade the immune system. The gG protein is unique to HSV-2 and is not found in HSV-1, making it a valuable target for diagnostic assays and vaccine development.
Recombinant gG refers to the glycoprotein G that has been produced using recombinant DNA technology. This involves inserting the gene encoding gG into a suitable expression system, such as bacteria, yeast, or mammalian cells, to produce the protein in large quantities. Recombinant gG is used in various applications, including:
The production of recombinant gG involves several steps:
The use of recombinant gG has several significant applications: